Veloxis Pharmaceuticals, Inc. v. Glenmark Pharmaceuticals Inc., USA
| Delaware District Court | |
| Judge: | Maryellen Noreika |
| Case #: | 1:25-cv-00458 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Apr 14, 2025 |
| Last checked: Wednesday Apr 16, 2025 1:57 AM EDT |
|
Defendant
Glenmark Pharmaceuticals Inc., USA
|
|
|
Plaintiff
Veloxis Pharmaceuticals, Inc.
|
Represented By
|
| Docket last updated: 12 hours ago |
| Wednesday, April 16, 2025 | ||
|
utility
Case Assigned/Reassigned
Wed 04/16 12:01 PM
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (alb) |
||
| Tuesday, April 15, 2025 | ||
| 7 | 7
service
Summons Returned Executed
Tue 04/15 12:38 PM
SUMMONS Returned Executed by Veloxis Pharmaceuticals, Inc..Glenmark Pharmaceuticals Inc., USA served on 4/15/2025, answer due 5/6/2025. (Tigan, Jeremy) |
|
| 6 | 6
service
Summons Issued
Tue 04/15 8:49 AM
Summons Issued as to Glenmark Pharmaceuticals Inc., USA on 4/15/2025. (slk) |
|
| Monday, April 14, 2025 | ||
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Tue 04/15 8:47 AM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Asahi Kasei Corp. for Veloxis Pharmaceuticals, Inc. filed by Veloxis Pharmaceuticals, Inc.. (slk) |
|
| 4 | 4
misc
Patent/Trademark Report to Commissioner of Patents
Tue 04/15 8:45 AM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,685,998 B2; 9,549,918 B2; 10,166,190 B2; 10,864,199 B2 ; 11,110,081 B2. (slk) |
|
| 3 | 3
misc
ANDA Form
Tue 04/15 8:44 AM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than March 4, 2025. Date of Expiration of Patent: U.S. Patent No. 8,685,998 expires on August 30, 2028, U.S. Patent Nos. 9,549,918; 10,166,190; 10,864,199; 11,110,081, 11,123,331, 11,419,823, and 12,083,103 expire on May 30, 2028. Thirty Month Stay Deadline: 9/4/2027. (slk) |
|
| 2 | 2
misc
Magistrate Consent Forms
Tue 04/15 8:41 AM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) |
|
| 1 | 1
22
pgs
cmp
Complaint
Tue 04/15 8:40 AM
COMPLAINT against Glenmark Pharmaceuticals Inc., USA (Filing fee $ 405, receipt number ADEDC-4661780) - filed by Veloxis Pharmaceuticals, Inc.(slk) |
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Exhibit C,
|
||
|
Att: 4
Exhibit D,
|
||
|
Att: 5
Exhibit E,
|
||
|
Att: 6
Exhibit F,
|
||
|
Att: 7
Exhibit G,
|
||
|
Att: 8
Exhibit H,
|
||
|
Att: 9
Exhibit I,
|
||
|
Att: 10
Civil Cover Sheet
|
||